$6.20
0.9417.87%
In chiusura: -
$6.17
-0.03-0.48%
After hour: 7:58 PM EDT
Comments
Loading...
Stime degli utili, EPS e fatturato
Bolt Biotherapeutics segnala gli utili su base trimestrale. Questi report sugli utili trimestrali offrono agli investitori uno sguardo ai risultati finanziari di un'azienda per un periodo di 3 mesi. I report sugli utili includono quasi sempre i risultati EPS e i ricavi.
Data degli utili
nov 11
Stima EPS
$-5.340
Stima dei ricavi trimestrali
$900.60K
Ricavi annuali
(a partire da giu 30)
(a partire da giu 30)
$4.17M
Analizza lo storico degli utili di Bolt Biotherapeutics utilizzando ordinamenti e filtri avanzati.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
BOLT | Bolt Biotherapeutics | -$8.00 | -$5.34 | — | — | $1.14M | $900.60K | — | — | 11/11/2025 | |
BOLT | Bolt Biotherapeutics | -$11.20 | -$6.32 | -$4.46 | 29.43% | $1.27M | $907.85K | $1.80M | 98.71% | 08/14/2025 | |
BOLT | Bolt Biotherapeutics | -$5.60 | -$6.40 | -$5.80 | 9.38% | $5.27M | $1.02M | $1.22M | 19.80% | 05/12/2025 | |
BOLT | Bolt Biotherapeutics | -$9.40 | -$7.60 | -$7.60 | 0.00% | $2.09M | $790.00K | $0.00 | -100.00% | 03/24/2025 | |
BOLT | Bolt Biotherapeutics | -$8.60 | -$7.00 | -$8.00 | -14.29% | $2.53M | $1.26M | $1.14M | -9.44% | 11/12/2024 | |
BOLT | Bolt Biotherapeutics | -$9.60 | -$9.60 | -$11.20 | -16.67% | $1.43M | $891.50K | $1.27M | 43.02% | 08/13/2024 | |
BOLT | Bolt Biotherapeutics | -$9.00 | -$10.20 | -$5.60 | 45.10% | $1.83M | $2.06M | $5.27M | 156.02% | 05/14/2024 | |
BOLT | Bolt Biotherapeutics | -$10.60 | -$9.60 | -$9.40 | 2.08% | $1.41M | $1.71M | $2.09M | 22.16% | 03/21/2024 | |
BOLT | Bolt Biotherapeutics | -$11.60 | -$10.00 | -$8.60 | 14.00% | $2.11M | $1.72M | $2.53M | 46.98% | 11/09/2023 | |
BOLT | Bolt Biotherapeutics | -$12.20 | -$9.80 | -$9.60 | 2.04% | $1.39M | $1.90M | $1.43M | -24.58% | 08/07/2023 | |
BOLT | Bolt Biotherapeutics | -$12.80 | -$10.20 | -$9.00 | 11.76% | $813.00K | $1.31M | $1.83M | 39.39% | 05/11/2023 | |
BOLT | Bolt Biotherapeutics | -$14.60 | -$12.00 | -$10.60 | 11.67% | $508.00K | $1.23M | $1.41M | 14.72% | 03/29/2023 | |
BOLT | Bolt Biotherapeutics | -$12.60 | -$11.20 | -$11.60 | -3.57% | $752.00K | $980.00K | $2.11M | 115.51% | 11/10/2022 | |
BOLT | Bolt Biotherapeutics | -$12.80 | -$13.60 | -$12.20 | 10.29% | $0.00 | — | $1.39M | — | 08/10/2022 | |
BOLT | Bolt Biotherapeutics | -$22.80 | — | -$12.80 | — | $0.00 | — | $813.00K | — | 05/12/2022 | |
BOLT | Bolt Biotherapeutics | -$291.60 | -$16.40 | -$14.60 | 10.98% | $0.00 | $370.00K | $508.00K | 37.30% | 03/30/2022 | |
BOLT | Bolt Biotherapeutics | — | -$13.20 | -$12.60 | 4.55% | — | $370.00K | $752.00K | 103.24% | 11/09/2021 | |
BOLT | Bolt Biotherapeutics | — | -$8.60 | -$12.80 | -48.84% | — | $3.33M | $0.00 | -100.00% | 08/12/2021 | |
BOLT | Bolt Biotherapeutics | -$83.20 | -$12.00 | -$22.80 | -90.00% | — | — | $0.00 | — | 05/13/2021 | |
BOLT | Bolt Biotherapeutics | — | -$11.00 | -$291.60 | -2550.91% | — | — | $0.00 | — | 03/31/2021 |
Bolt Biotherapeutics (BOLT) Guadagno per azione
Importo a sorpresa sugli utili trimestrali
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $-4.46 | $-6.32 | 29.4 % |
| Q1 | 2025-05-12 | $-5.80 | $-6.40 | 9.38 % |
| Q4 | 2025-03-24 | $-7.60 | $-7.60 | 0.00 % |
| Q3 | 2024-11-12 | $-8.00 | $-7.00 | -14.3 % |
Bolt Biotherapeutics (BOLT) Entrate
Importo sorpresa sulle entrate trimestrali
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | 2025-08-14 | $1.80M | $907.85K | 98.7 % |
| Q1 | 2025-05-12 | $1.22M | $1.02M | 19.8 % |
| Q4 | 2025-03-24 | $0 | $790.00K | -100.0 % |
| Q3 | 2024-11-12 | $1.14M | $1.26M | -9.44 % |
FAQ
Quando Bolt Biotherapeutics (NASDAQ:BOLT) riporterà gli utili?
Si prevede che Bolt Biotherapeutics (BOLT) fornisca risultati il novembre 11, 2025. Gli ultimi risultati sono stati pubblicati il agosto 14, 2025 per il Q2.
Quali sono stati gli ultimi utili per azione (EPS) di Bolt Biotherapeutics (NASDAQ:BOLT)?
L'EPS effettivo era $-4.46, che superato la stima di $-6.32.
Quali sono state le entrate di Bolt Biotherapeutics (NASDAQ:BOLT)?
Le entrate effettive sono state $1.8M, che superato la stima di $907.9K.
Sfoglia stime sugli utili, EPS e ricavi su tutte le azioni.